뉴스벤징가
Natera Secures Landmark Japan Nod For Signatera In Colorectal Cancer
· 발표
기사 요약
Natera won Japan approval for Signatera in colorectal cancer, paving the way for a commercial launch by 2026.
기사 원문에서 발췌했어요.Natera won Japan approval for Signatera in colorectal cancer, paving the way for a commercial launch by 2026.
기사 원문에서 발췌했어요.
댓글 —
댓글을 불러오고 있어요…